Immunocore Holdings Plc
Immunocore Holdings plc is a pioneering biotechnology company focused on developing transformative immunomodulating therapies to improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases. Their proprietary ImmTAX technology enhances the immune system's ability to target and destroy diseased cells.
Founded: 7 Jan 2021
Industries:
64209 - Activities of other holding companies n.e.c.72190 - Other research and experimental development on natural sciences and engineering
Website: immunocore.com
Phone: +441235438600
Email: compliance@immunocore.com
Location: Abingdon
Products & Services
• autoimmune diseases
• bispecific t cell receptor therapies
• cancer treatment
• clinical trial collaborations
• clinical trials
• imc-f106c (prame hla-a02)
• immunotherapy
• immunotherapy development
• infectious diseases
• pharmaceutical company
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
8
Shareholders
5
Controllers (PSC)
1
Kristine Peterson
Director • American • Lives in United States • Born in Aug 1959
John Irving Bell
Director • British,canadian • Lives in United Kingdom • Born in Jul 1952
Bahija Jallal
Director • American,moroccan • Lives in United States • Born in May 1961
Roy Steven Herbst
Director • American • Lives in United States • Born in Jan 1963
Siddharth Kaul
Director • American • Lives in United States • Born in Aug 1960
Basic Information
PLC
7 Jan 2021
ENGLAND WALES
Yes
Industry Classification
64209, 72190
Company Attributes
N/A
N/A
N/A
N/A
Summary
11
Officers
1
PSCs
0
Filings